| Fishman, Mark (Novartis Institutes of BioMedical Research 200509 President) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Fitzgerald, Daniel (Geneva Biotech 201711 CEO) |
Chief Executive Officer (CEO) |
Geneva Biotech (CH) |
Switzerland |
| FitzGerald, Kevin (Activiomics 201304– CEO F-Star 201104–201205 CEO LEFT 5/12 + Isogenica + CAT) |
Chief Executive Officer (CEO) |
F-Star (Group) |
Austria |
| FitzGerald, Peter (Randox Laboratories 200710 Managing Director) |
Managing Director |
Randox (Group) |
United Kingdom (GB) |
| Fitzpatrick, David (Max Planck 201212– Scientific Director + CEO of MPFI) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
United States (USA) |
| Flach, Jürgen (Sirion Biotech 201106 Managing Director CEO) |
Chief Executive Officer (CEO) |
PerkinElmer (Group) |
Germany |
| Flad, Thomas (PANATecs 201104 Head Technical Sales before 200512 Managing Director) |
Sales Manager / Marketing Manager |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Flade, Isabell (CeMeT GmbH 201407– Managing Director) |
Managing Director |
CeMeT GmbH – Center for Metagenomics |
Germany |
| Fladrich, Mark (Grünenthal 201709– CCO before AstraZeneca) |
Chief Commercial Officer (CCO) |
Grünenthal (Group) |
Germany |
| Flamm, Robert (Burns McClellan 202103 before Ruth Group 201612) |
Public Relations Manager / Investor Relations Manager |
Burns McClellan Inc. |
United States (USA) |
| Flatman, Steve (Lonza 201101 Head Mammalian Development Services) |
Research & Development Manager |
Lonza (Group) |
Switzerland |
| Fleck, Roman (Index Ventures 2006– Principal at Geneva office before Boehringer Ingelheim) |
Principal (venture capital) |
Index Ventures |
Switzerland |
| Fleck, Stephan (Whatman 200711– before Bayer) |
n. a. |
General Electric (Group) |
United Kingdom (GB) |
| Fleckenstein, Tamara (Elementar 201701 Event + External Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Elementar (Group) |
Germany |
| Fleig, Thomas (Valerius Bioharma 201805 CFO before Ernst & Young) |
Chief Financial Officer (CFO) |
Valerius Biopharma AG |
Switzerland |
| Fleiner, Mark (Spectris 202201 President of Malvern Panalytical) |
President/Director/Head Business Group/Unit/Division |
Spectris (Group) |
United Kingdom (GB) |
| Fleming, Bill (Oxitec 201704 CFO joined 2010 before Bayer + OBN 201704– Board Member) |
Chief Financial Officer (CFO) |
Third Security (Randal J. Kirk) (Group) |
United Kingdom (GB) |
| Flenker, Ulrich (German Sport University 200804) |
n. a. |
Deutsche Sporthochschule Köln |
Germany |
| Flensberg, Mikael (CLC bio 201304 Director Global Partner Relations) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Denmark |
| Fleurant, Mylène (Novimmune 201609– Global Head of Quality before Alvotech + Novartis Pharma + Merck Serono) |
Chief Financial Officer (CFO) |
Novimmune S.A. |
Switzerland |
| Fließbach, Holger (Alopex 200507– Managing Director) |
Managing Director |
Alopex GmbH |
Germany |
| Flintholm Jørgensen, Keld (Lundbeck 201904– EVP + CBO before Roche Global Head of Strategic Partnering) |
Chief Business Officer (CBO) |
Lundbeck (Group) |
Denmark |
| Flon, Aude (Sud de France 201111 Project Manager Multi-industrial Sector) |
Administrative Officer (personnel) |
Sud de France Développement |
France |
| Flores, Lalo (Century Therapeutics 201907 CEO) |
Chief Executive Officer (CEO) |
Century Therapeutics (US) |
United States (USA) |
| Floß, Georg (Biotest 201301– promoted COO joined Biotest 2/08) |
Chief Operating Officer (COO) |
Grifols (Group) |
Germany |
| Flückiger-Mangual, Stefanie (201809 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Tolremo Therapeutics AG |
Switzerland |
| Flöß, Lukas (Inovedis 202106 Managing Director + Co-Founder) |
Managing Director |
Inovedis GmbH |
Germany |
| Focant, Jean-François (Univ Liège 201710 Prof + Director of OBiAChem) |
Professor |
University of Liège, Organic and Biological Analytical Chemistry Laboratory (OBiAChem) |
Belgium |
| Foidart, Marc (Épimède 201711 Investment Manager) |
Investment Manager |
Noshaq S.A. |
Belgium |
| Fontoura, Alexandre (SGS 201610 Business Manager at SGS Brazil) |
Business Development Manager / Strategy Manager |
SGS (Group) |
Brazil |
| Foos, Christian (Berlin Capital Fund 200504) |
n. a. |
Triginta Capital (Group) |
Germany |
| Forer, Michael (Celtic Therapeutics 201207 CEO of ADC Therapeutics until 6/15 + Partner in Celtic Therapeutics) |
Chief Executive Officer (CEO) |
ADC Therapeutics (Group) |
Switzerland |
| Formela, Jean-François (Atlas Venture 201205 Partner joined 1993 before Schering-Plough) |
Partner (venture partner) |
Atlas Venture (Group) |
United States (USA) |
| Fornaroli, Micol (Bracco 201710 Chief Strategy Officer at Bracco Imaging SpA) |
Business Development Manager / Strategy Manager |
Bracco (Group) |
Italy |
| Forrest, Rosanna (Instinctif Partners 201603) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
| Forsberg, Erik (Uppsala BIO 201109 Managing Director) |
Managing Director |
Uppsala BIO |
Sweden |
| Forsberg, Roald (Indivumed 202101– CBO joined 2019 formerly CLC bio 200806 Director Scientific Solutions) |
Chief Business Officer (CBO) |
Indivumed (Group) |
Germany |
| Forster, Eliot (F-Star 201810– CEO before Immunocore + Creabilis + Solace Pharmaceuticals + Pfizer + GSK) |
Chief Executive Officer (CEO) |
F-Star (Group) |
United Kingdom (GB) |
| Forster, Vincent (Versantis AG 201704 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Versantis AG |
Switzerland |
| Foster, James C. (Charles River 200708 President + CEO) |
Chief Executive Officer (CEO) |
Charles River (Group) |
United States (USA) |
| Foster, Jason C. (Oribiotech 202001– CEO) |
Chief Executive Officer (CEO) |
Oribiotech Ltd. (d/b/a Ori Biotech) |
United Kingdom (GB) |
| Foster, John (Owl Biomedical Inc 201404 President) |
President/Director/Head Business Group/Unit/Division |
Miltenyi Biotec (Group) |
United States (USA) |
| Fotev, Zisi (Cenix BioScience 200502 CBO) |
Chief Business Officer (CBO) |
Cenix BioScience (Group) |
Germany |
| Fotin-Mleczek, Mariola (CureVac 201710 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
CureVac (Group) |
Germany |
| Foulger, Paul (EKF Diagnostics 201307– Interim Finance Director before Company Secretary) |
Chief Financial Officer (CFO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Fouquet, Gerhard (Univ Kiel 201201 President + Professor) |
President/Director/Head Business Group/Unit/Division |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
| Fournier, Jennifer (Waters 201902 Director Product Marketing Chemistry Group) |
Sales Manager / Marketing Manager |
Waters (Group) |
United States (USA) |
| Fowler, Sanna (Lonza 201809 Head PR Lonza Pharma & Biotech) |
Public Relations Manager / Investor Relations Manager |
Lonza (Group) |
Switzerland |
| Fowles, Richard (United Kingdom (govt) 201010 Category Manager at RCUK SSC Ltd) |
n. a. |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Foy, Shaun P. (CRISPR Therapeutics 201404 CFO + Co-Founder + ERS Genomics CEO + Co-Founder before Nomura Phase4) |
Chief Financial Officer (CFO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Foy, Teri (BMS 202112 SVP Research + Early Development, Immuno-Oncology + Cell Therapy) |
President/Director/Head Business Group/Unit/Division |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Frahm, Thomas (TRI Thinking Reseach Instruments 202205 Head of Sales + BusDev formerly Norgenta) |
Cluster Manager |
TRI Thinking Research Instruments GmbH |
Germany |
| Francis, Richard (Novartis 201404– Divison Head of Sandoz before Biogen Idec + Sanofi + Wyeth) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Franco, Nicholas (Actelion 201106 Chief Business Developm Officer before Axcan Pharma Paris before Novartis Pharma AG) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
| Francoise, Jacques (CSM Instruments –201311 General Manager) |
General Manager (management) |
Anton Paar (Group) |
Switzerland |
| Frank, Gert (Geratherm 201507 CEO) |
Chief Executive Officer (CEO) |
Geratherm (Group) |
Germany |
| Frank, Hans-Georg (AplaGen 200810 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
AplaGen GmbH |
Germany |
| Frank, Peter (ScanBalt 201105 General Sectretary) |
Administrative Officer (personnel) |
ScanBalt Network (Scanbalt MTÜ) |
Estonia |
| Franken, Sebastian (Univ Bonn 201101 IBMB Team Leader Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Frankenne, Günter (november 200611– ) |
n. a. |
November (Group) |
Germany |
| Franksson, Olof (HotSwap 201102 CEO) |
Chief Executive Officer (CEO) |
HotSwap (Group) |
Sweden |
| Frantsits, Werner (Sanochemia 201208 CEO) |
Chief Executive Officer (CEO) |
Sanochemia (Group) |
Austria |
| Franz, Christoph (Roche 201403– Board Chairman before Lufthansa CEO) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Franz, Oliver (Eppendorf 200804 Executive Director Portfolio Management PCR + Automation) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
| Franzen, Jochen (Bruker Daltonik) |
Company Founder |
Bruker (Group) |
Germany |
| Frasch, Markus (AppliChem 200904 Managing Director) |
Managing Director |
Illinois Tool Works (ITW) (Group) |
Germany |
| Fraser, Paul D. (Univ London 201403 Professor at Royal Holloway and Bedford New College) |
Professor |
University of London |
United Kingdom (GB) |
| Frauendorf, Holm (Univ Göttingen 200910 Head Div Zentrale Analytik) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Göttingen (Georg August University) |
Germany |
| Frearson, Julie (Charles River 201711 Corp VP Global Discovery Services) |
President/Director/Head Business Group/Unit/Division |
Charles River (Group) |
United States (USA) |
| Frech, Kornelie (Genomatix 200608 Head of Biological Databases) |
n. a. |
Genomatix Software (Group) |
Germany |
| Fréchet, Jean M. J. (KAUST 201803 Prof + SVP Research + Innovation + Economic Development) |
Professor |
King Abdullah University of Science and Technology (KAUST) |
Saudi Arabia |
| Freedman, Stephen (Gladstone Institutes 201507 VP Corporate Liaison + Ventures) |
Business Development Manager / Strategy Manager |
Gladstone Institutes (Group) |
United States (USA) |
| Freeman, David M. (Cell Signaling Technology 201301 Head of Global Marketing) |
Sales Manager / Marketing Manager |
Cell Signaling Technology (CST) (Group) |
United States (USA) |
| Fregien, Jörg (Life Science Inkubator 201103 Managing Director) |
Managing Director |
Life Science Inkubator GmbH (LSI) |
Germany |
| Frei, Patrik (Venture Valuation 201802 CEO + Founder) |
Chief Executive Officer (CEO) |
Venture Valuation (Group) |
Switzerland |
| Freier, Gottfried W. (Kaye Scholer LLP 200809 Frankfurt/M) |
Attorney / Lawyer |
Arnold & Porter LLP |
Germany |
| Freischem, Barbara (EBE 201609 Executive Director) |
lobbying |
EFPIA (European Federation of Pharmaceutical Industries Associations) |
Belgium |
| Freitag, Chris (Dynacure 201807– CMO before Debioparm + BTG plc + Shire + Roche) |
Chief Medical Officer (CMO) |
Dynacure S.A.S. |
France |
| French, Hayley (Apitope 201810– COO + interim CEO before CBO + General Counsel since 11/10 before Novartis) |
Chief Operating Officer (COO) |
Apitope (Group) |
Belgium |
| Frenkl, Tara (Bayer 202204– Head of Oncology Development at Oncology Strategic Business Unit before GSK + Merck (US)) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Frenzel, Bernd (Biochrom AG 201110 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Freudenberg, Rainer (CMS 201408 Associate at CMS Hasche Sigle Ffm) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Frey, Claudia (Cytosurge 202103 Marketing Manager) |
Sales Manager / Marketing Manager |
Cytosurge AG |
Switzerland |
| Frey, Olivier (InSphero 2016– Microphysiological Systems Product Manager before ETHZ) |
Product Manager (personnel) |
InSphero (Group) |
Switzerland |
| Freyberg, Mark-Andre (CytoTools 201111 Managing Director) |
Managing Director |
CytoTools (Group) |
Germany |
| Freyer, Ralf (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
| Fricke, Harald (Apogenix GmbH 200511– CMO + COO before Fresenius Biotech + Baxter + GSK) |
Chief Medical Officer (CMO) |
Apogenix AG |
Germany |
| Frickel, Fritz (Therascope 200307 CEO) |
Chief Executive Officer (CEO) |
Amgen (Group) |
Germany |
| Friebe, Margaret (m2f Investment Ltd 201305 Managing Director) |
Investment Manager |
m2f Investment Ltd. (DE) |
Germany |
| Friebe, Michael (m2f Investment Ltd 201305 Managing Director) |
Investment Manager |
m2f Investment Ltd. (DE) |
Germany |
| Friedemann, Susan (CCS Cell Culture Service 201007 Sales & Communication) |
Sales Manager / Marketing Manager |
Evotec (Group) |
Germany |
| Friedhoff, Paul (Bruker-Quantron GmbH 200609– Managing Director before Quantron GmbH Managing Director) |
Managing Director |
Bruker (Group) |
Germany |
| Friedman, Gary (Novartis 201007 Medical Director – Infectious Disease, Transplantation + Immunology) |
Chief Medical Officer (CMO) |
Novartis (Group) |
Switzerland |
| Friedman, Isaac (Abbott 201203 Head of STARLIMS business) |
President/Director/Head Business Group/Unit/Division |
Abbott (Group) |
Israel |
| Friedman, Michael (AmniSure International 201205 CEO) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
United States (USA) |
| Friedman, Paul A. (Incyte 201401 non-executive Board Member before CEO) |
Board member, non-executive |
Incyte Corporation (Group) |
United States (USA) |
| Friedrich, Alex (Univ Groningen 201203 Prof + Chair Medical Microbiology and Infection Control at UMCG) |
Professor |
University of Groningen (Rijksuniversiteit Groningen) |
Netherlands |
| Friedrich, Benjamin (Temedica 202201 CMO) |
Chief Medical Officer (CMO) |
Temedica GmbH |
Germany |
| Friedrich, Colette (BianoScience GmbH 2010– CFO before Osram Sylvania) |
Chief Financial Officer (CFO) |
BianoScience GmbH |
Germany |
| Friedrich, Eva (SDL 201604 Field Marketing Manager DACH) |
n. a. |
SDL (Group) |
United Kingdom (GB) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px](/banner/iito-business-intelligence-20220406-650-100-promote-brand-to-decision-makers.jpg)
1 2 3 ... 19 20 21 ... 79 80 81 
![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
